Ultraslow microdialysis and microfiltration for in-line, on-line and off-line monitoring

J. Korf, K.D. Huinink, G.A. Posthuma-Trumpie

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)

Abstract

In medicine and biotechnology, close monitoring of molecular processes might assist to optimise therapeutic interventions and production of biochemicals, respectively. Here, we summarize the current status of two automatic and continuous sampling technologies, microdialysis and microfiltration, which facilitate both in vivo and in vitro monitoring of nearly any analyte, because they can be combined easily with many analytical techniques. Conventional microdialysis and microfiltration, which require collecting relatively large samples, are however often impractical and semi-quantitative; hence, we focus on ultraslow sampling to circumvent such limitations. Ultraslow microdialysis and microfiltration already have been used successfully for quantitative pharmacokinetics, glucose metabolism (e.g. of the brain), cytokines and proteomics (e.g. tumour secretomes), both in vivo and in vitro.
Original languageEnglish
Pages (from-to)150-158
JournalTrends in Biotechnology
Volume28
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

Microfiltration
Microdialysis
Monitoring
Sampling
Pharmacokinetics
Biotechnology
Metabolism
Proteomics
Medicine
Glucose
Tumors
Brain
Cytokines
Technology
Neoplasms
In Vitro Techniques
Therapeutics

Keywords

  • mass-spectrometric proteomics
  • ultrafiltration probes
  • quantitative microdialysis
  • protein-adsorption
  • inflammatory response
  • blood compatibility
  • vivo microdialysis
  • adipose-tissue
  • hollow-fiber
  • lactate

Cite this

@article{5f8e58b71dab427eab3ad26d177224ad,
title = "Ultraslow microdialysis and microfiltration for in-line, on-line and off-line monitoring",
abstract = "In medicine and biotechnology, close monitoring of molecular processes might assist to optimise therapeutic interventions and production of biochemicals, respectively. Here, we summarize the current status of two automatic and continuous sampling technologies, microdialysis and microfiltration, which facilitate both in vivo and in vitro monitoring of nearly any analyte, because they can be combined easily with many analytical techniques. Conventional microdialysis and microfiltration, which require collecting relatively large samples, are however often impractical and semi-quantitative; hence, we focus on ultraslow sampling to circumvent such limitations. Ultraslow microdialysis and microfiltration already have been used successfully for quantitative pharmacokinetics, glucose metabolism (e.g. of the brain), cytokines and proteomics (e.g. tumour secretomes), both in vivo and in vitro.",
keywords = "mass-spectrometric proteomics, ultrafiltration probes, quantitative microdialysis, protein-adsorption, inflammatory response, blood compatibility, vivo microdialysis, adipose-tissue, hollow-fiber, lactate",
author = "J. Korf and K.D. Huinink and G.A. Posthuma-Trumpie",
note = "ISI:000275605100006",
year = "2010",
doi = "10.1016/j.tibtech.2009.12.005",
language = "English",
volume = "28",
pages = "150--158",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier",
number = "3",

}

Ultraslow microdialysis and microfiltration for in-line, on-line and off-line monitoring. / Korf, J.; Huinink, K.D.; Posthuma-Trumpie, G.A.

In: Trends in Biotechnology, Vol. 28, No. 3, 2010, p. 150-158.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Ultraslow microdialysis and microfiltration for in-line, on-line and off-line monitoring

AU - Korf, J.

AU - Huinink, K.D.

AU - Posthuma-Trumpie, G.A.

N1 - ISI:000275605100006

PY - 2010

Y1 - 2010

N2 - In medicine and biotechnology, close monitoring of molecular processes might assist to optimise therapeutic interventions and production of biochemicals, respectively. Here, we summarize the current status of two automatic and continuous sampling technologies, microdialysis and microfiltration, which facilitate both in vivo and in vitro monitoring of nearly any analyte, because they can be combined easily with many analytical techniques. Conventional microdialysis and microfiltration, which require collecting relatively large samples, are however often impractical and semi-quantitative; hence, we focus on ultraslow sampling to circumvent such limitations. Ultraslow microdialysis and microfiltration already have been used successfully for quantitative pharmacokinetics, glucose metabolism (e.g. of the brain), cytokines and proteomics (e.g. tumour secretomes), both in vivo and in vitro.

AB - In medicine and biotechnology, close monitoring of molecular processes might assist to optimise therapeutic interventions and production of biochemicals, respectively. Here, we summarize the current status of two automatic and continuous sampling technologies, microdialysis and microfiltration, which facilitate both in vivo and in vitro monitoring of nearly any analyte, because they can be combined easily with many analytical techniques. Conventional microdialysis and microfiltration, which require collecting relatively large samples, are however often impractical and semi-quantitative; hence, we focus on ultraslow sampling to circumvent such limitations. Ultraslow microdialysis and microfiltration already have been used successfully for quantitative pharmacokinetics, glucose metabolism (e.g. of the brain), cytokines and proteomics (e.g. tumour secretomes), both in vivo and in vitro.

KW - mass-spectrometric proteomics

KW - ultrafiltration probes

KW - quantitative microdialysis

KW - protein-adsorption

KW - inflammatory response

KW - blood compatibility

KW - vivo microdialysis

KW - adipose-tissue

KW - hollow-fiber

KW - lactate

U2 - 10.1016/j.tibtech.2009.12.005

DO - 10.1016/j.tibtech.2009.12.005

M3 - Article

VL - 28

SP - 150

EP - 158

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 3

ER -